- Sculptor Lalanne's animal creations sell for $59 mn
- From Tesla to Trump: Behind Musk's giant leap into politics
- US, European markets rise as investors weigh rates, earnings
- In Colombia, children trade plastic waste for school supplies
- Supercharged hurricanes trigger 'perfect storm' for disinformation
- JPMorgan Chase profits top estimates, bank sees 'resilient' US economy
- Djokovic proves staying power as he progresses to Shanghai semi-finals
- Sheffield Utd boss Wilder 'numb' after Baldock death
- Little progress at key meet ahead of COP29 climate summit
- Fans immerse themselves in Marina Abramovic's first China exhibition
- Israel says conducting review after UN peacekeepers wounded in Lebanon
- 'Party atmosphere': Skygazers treated to another aurora show
- Djokovic 'overwhelmed' after 'greatest rival' Nadal's retirement
- Zelensky in Berlin says hopes war with Russia will end next year
- Kyrgyzstan opens rare probe into glacier destruction
- European Mediterranean states discuss Middle East, migration
- Djokovic proves staying power as progresses to Shanghai semi-finals
- Hurricane Milton leaves at least 16 dead as Florida cleans up
- Britain face 'ultimate challenge' in America's Cup duel with New Zealand
- Lebanon calls for 'immediate' ceasefire in Israel-Hezbollah war
- Nihon Hidankyo: Japan's A-bomb survivors awarded Nobel
- Thunberg leads pro-Palestinian, climate protest in Milan
- Boat captain rescued clinging to cooler in Gulf of Mexico after storm Milton
- Tears, warnings after Japan atomic survivors group win Nobel
- 'Unspeakable horror': the attacks on Hiroshima and Nagasaki
- Stock markets diverge before China weekend briefing
- Christian villagers 'trapped' in south Lebanon crossfire
- Sabalenka sets up Gauff showdown in Wuhan semis
- EU questions shopping app Temu over illegal products risk
- Kim Sei-young holds lead with late birdies at LPGA Shanghai
- Toulouse welcome Dupont 'boost' as Olympic star returns to Top 14
- Japanese atomic bomb survivor group Nihon Hidankyo wins Nobel Peace Prize
- Deadly Israeli strike on Beirut likely targeted Hezbollah security chief
- Bangladesh Islamist chief backs crimes against humanity trial for ex-PM
- Everest climber's remains believed found after 100 years
- 20 Pakistan coal miners shot dead in attack
- Clashes on South China Sea, Ukraine dominate Asia summit
- Han Kang's books sell out in South Korea after Nobel win
- Zelensky meets Pope, Scholz as whirlwind Europe tour ends
- Hello Hallyu: why is South Korean culture sweeping the globe?
- UK economy rebounds in August in boost to new govt
- Voice of Japan's beloved robot cat 'Doraemon' dies
- Shanghai markets sink ahead of briefing on mixed day for Asia
- Investors, analysts eye bigger China stimulus at Saturday briefing
- 20 Pakistan coal miners shot dead in attack: police
- Blinken condemns China's 'increasingly dangerous' sea moves
- Toyota returns to Formula One as Haas partner
- EU chief says China must 'adapt its behaviour' to solve trade row
- Musk unveils robotaxi, pledges it 'before 2027'
- Lynx rally, stun Liberty in overtime in WNBA Finals opener
CMSC | 0.24% | 24.65 | $ | |
RBGPF | -1.03% | 59.49 | $ | |
RYCEF | 0.58% | 6.92 | $ | |
BCC | 1.84% | 141.56 | $ | |
SCS | 2.1% | 12.87 | $ | |
GSK | -1.13% | 38.77 | $ | |
RELX | 1.09% | 46.87 | $ | |
RIO | 0.17% | 66.955 | $ | |
NGG | 0.68% | 66.13 | $ | |
BCE | -0.21% | 32.79 | $ | |
VOD | -1.09% | 9.635 | $ | |
CMSD | 0.51% | 24.898 | $ | |
AZN | 0.36% | 77.15 | $ | |
JRI | 0.11% | 13.235 | $ | |
BP | -0.76% | 32.095 | $ | |
BTI | -0.15% | 35.058 | $ |
US high court to hear challenge to $6bn Purdue opioid settlement
The US Supreme Court is to hear a challenge on Monday to Purdue Pharma's $6 billion opioids settlement immunizing the family that controlled the drugmaker from future litigation.
The Justice Department is arguing that members of the Sackler family, who earned tens of billions of dollars flooding the country with highly addictive opioids, should not legally gain sweeping protection in the deal.
Last year's settlement, which came after years of negotiations involving legal officials from all 50 US states, set aside $6 billion from the bankruptcy of Purdue, which made prescription painkillers like OxyContin, for victims of the opioid epidemic.
At the same time, the settlement, which was approved by a lower court, gave the families of Raymond Sackler and Mortimer Sackler protection from all future civil claims, effectively protecting their other assets from opioid-related lawsuits.
The Supreme Court put the settlement on hold at the request of the Justice Department, pending Monday's oral arguments.
In its complaint, the Justice Department said the Sacklers withdrew $11 billion from Purdue over the 11 years before the company filed for bankruptcy protection in 2019.
Purdue's bankruptcy filing resulted directly from the massive, country-wide litigation against it and other major drugmakers and pharmacy companies for knowingly fomenting the addiction crisis.
The March 2022 settlement said the Sacklers were "absolutely, unconditionally, irrevocably, fully, finally, forever and permanently" released from further legal liability.
But the Justice Department said the Chapter 11 bankruptcy code which governed the settlement does not provide for such immunization, especially because there could be "an untold number of claimants" who did not agree to the terms of the settlement.
If allowed, the Purdue deal would "leave in place a roadmap" for companies to turn to bankruptcy to protect themselves from civil suits, it said.
In addition, "it allows the Sacklers to shield billions of dollars of their fortune while extinguishing, without payment, claims alleging trillions of dollars in damages," the department said.
"The plan violates the basic tradeoff of bankruptcy that, in exchange for a fresh start, a debtor must commit essentially all assets to satisfying claims against it," it said.
- Over 500,000 deaths -
Purdue has said it is confident in the legality of the deal.
It has criticized the Justice Department for delaying billions of dollars being "put to use for victim compensation, opioid crisis abatement for communities across the country, and overdose rescue medicines."
The opioid addiction epidemic has caused more than 500,000 overdose deaths in the United States over two decades, authorities say.
Purdue and other opioid makers and distributors were accused of encouraging free-wheeling prescription of their products through aggressive marketing tactics while hiding how addictive the drugs are.
Facing an avalanche of litigation, in 2021 Purdue pled guilty to three criminal charges over its marketing of OxyContin.
The Sacklers have consistently denied wrongdoing over the opioid epidemic.
A.Mahlangu--AMWN